Fig. 3.

Fig. 3. Effect of prebiotics on the expression of galectin-9, filaggrin, and TSLP in the mesenteric lymph nodes (MLN). C: Untreated control, N: AD control (DNCB-induced), P: Zyrtec-positive control (DNCB-induced + Zyrtec), T1: scGOS/lcFOS (DNCB-induced + scGOS/lcFOS), T2: Inulin (DNCB-induced + Inulin), T3: β-glucan (DNCB-induced + β- glucan); *p < 0.05 versus control group, **p < 0.01 versus control group, #p < 0.05 versus negative control group, ##p < 0.01 versus negative control group. Data represent means ± SD of 4 replicates.

© J. Microbiol. Biotechnol.